Ultrasound can overcome some of the detrimental effects of aging and dementia without the need to cross the blood-brain barrier, researchers at Queensland Brain Institute (QBI) in Australia have found. Neuroscientist Jürgen Götz, PhD, led a multidisciplinary team at QBI’s Clem Jones Centre for Ageing Dementia Research, which showed that low-intensity ultrasound effectively restored cognition without opening the barrier in mice models.
The findings provide a potential new avenue for the noninvasive technology and will help clinicians tailor medical treatments that consider an individual’s disease progression and cognitive decline. “Historically, we have been using ultrasound together with small gas-filled bubbles to open the almost-impenetrable blood-brain barrier and get therapeutics from the bloodstream into the brain,” Götz says.
The new research involved a designated control group who received ultrasound without the barrier-opening microbubbles. “The entire research team was surprised by the remarkable restoration in cognition,” he says. “We conclude therapeutic ultrasound is a noninvasive way to enhance cognition in the elderly.”
Aging is associated with impaired cognition and a reduction in the learning induced plasticity of the signaling between neurons called long-term potentiation (LTP).
Daniel Blackmore, PhD, senior postdoctoral researcher on the team, says the new research aimed to use ultrasound to restore LTP and improved spatial learning in aged mice.
Götz says the brain was “not particularly accessible,” but ultrasound provided a tool for overcoming challenges like the blood-brain barrier. “Using ultrasound could enhance cognition independently of clearing amyloid and tau, which form plaques and tangles in people with Alzheimer’s disease,” he says. “Microbubbles will continue to be used in combination with ultrasound in ongoing Alzheimer’s research.”
Previous research has shown the long-term safety of ultrasound technology and that pathological changes and cognitive deficits could be improved by using ultrasound to treat Alzheimer’s disease. Götz says there were still questions about the differences between normal “physiological” aging and the “pathological” aging that happens in Alzheimer’s disease.
‘‘We believe there may be some overlap between physiological and pathological aging in the brain and the potential for this to be corrected with ultrasound is meaningful for those living with Alzheimer’s disease,” he says. ‘‘We are taking these findings and implementing them in our Alzheimer’s research as we go forward to clinical trials.’’
